FDA Approved: ALMOTRIPTAN MALATE — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva's almotriptan malate as an original ANDA, providing a generic option for the acute treatment of migraines.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine Without Aura
• Migraine with Aura

Drugs mentioned

• Almotriptan malate (almotriptan)

Snippet

ORIG AP for ALMOTRIPTAN MALATE (ALMOTRIPTAN MALATE)